Innate Pharma S.A. ( IPHA) - Key Metrics
IPHA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2024Q4 | $0.05 | -$0.30 | -$0.12 | -$0.12 |
| 2024Q2 | $0.15 | -$0.31 | $0.04 | $0.03 |
| 2023Q4 | $0.27 | -$0.12 | -$0.26 | -$0.26 |
IPHA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q2 | ? | ? |
| 2024Q4 | ? | -1.59 |
| 2024Q2 | ? | -1.60 |
| 2023Q4 | ? | -5.68 |
IPHA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | -17.25% | ? |
| 2025Q2 | -25.86% | ? |
| 2024Q4 | -6.97% | ? |
| 2024Q2 | 1.78% | ? |
| 2023Q4 | -10.35% | ? |
IPHA
Price: $1.76
52 week price:
Earnings Per Share: -0.64 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 6529
Market Capitalization: 168.1 million